AUG 14, 2015 4:59 PM PDT

Double Whammy

WRITTEN BY: Ilene Schneider
Getting cancer to go away is only part of the story.  Keeping it from coming back may require an entirely different strategy. When patients are given a drug to block part of the immune system from going into overdrive, it could keep the cancer coming back in some people, according to research published Cancer Research UK-funded scientists from the University of Sheffield in the journal Cancer Research and reported in Bioscience Technology (https://www.dddmag.com/news/2015/08/chemotherapy-immune-blocking-drug-combination-could-stop-cancer-growing-back?et_cid=4741651&et_rid=45505806&location=top).
UK researchers attempt to keep cancer from coming back.
The researchers discovered that the cancer-killing action of chemotherapy can trigger a horde of wound-healing, white blood cells that cluster around blood vessels in a treatment-affected tumor. Sometimes these M2 macrophages do too good a job. They repair tissue damage and build new blood vessels, which could help the tumor to grow again after treatment. On the other hand, if the mice with cancer are treated with a drug that stops these repair cells from working, the researchers could scale back the speed at which tumors grew back after chemotherapy.

Professor Claire Lewis at the University of Sheffield’s Department of Oncology, the lead scientist on the study, said, “Scientists already knew that the body’s drive to heal itself can sometimes backfire when the immune system reacts to tissue damage. Our research shows that treating tumors with chemotherapy can activate this part of the immune system, and this then helps tumors re-grow afterwards. But combining chemotherapy with a drug that switches off this part of the body’s repair system, slowed the growth of tumors after chemotherapy. This could be particularly important for patients who can’t have surgery and, therefore, need chemotherapy to help them live for as long as possible.”

The researchers will need clinical trials of patients to confirm that the drug can help cancer patients after chemotherapy. It is already used in patients for other reasons, such as bone marrow transplants -

According to Dr Áine McCarthy, science communications officer at Cancer Research UK, “Chemotherapy is a cornerstone cancer treatment that saves thousands of lives, but sometimes tumors come back, reducing patients’ chances of survival. We don’t understand all the reasons why tumors do come back, but this study sheds new light on the role of the immune system in causing tumors to grow again and, importantly, identifies a drug that could block this happening if given at the same time as chemotherapy. But this is early research carried out in mice and more work is needed to see if blocking M2 macrophages can also slow down tumor re-growth in patients.”
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
SEP 10, 2020
Cancer
Pancreatic cancer patients see hope in this newly developed drug
SEP 10, 2020
Pancreatic cancer patients see hope in this newly developed drug
A new drug developed by researchers at the University of Sheffield hopes to improve life expectancy and quality of life ...
SEP 22, 2020
Cardiology
Investigating the Mechanism Behind 5-Fluorouracil's Cardiotoxicity
SEP 22, 2020
Investigating the Mechanism Behind 5-Fluorouracil's Cardiotoxicity
Cancer therapies have come quite far, with several options available for many cancers. An issue that has plagued many of ...
OCT 07, 2020
Cancer
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
OCT 07, 2020
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
Over the years, cancer researchers have struggled not just with drug and diagnostic design, but with drug delivery. The ...
OCT 08, 2020
Immunology
Immuno Metabolic Complexity and Modulating Metabolites
OCT 08, 2020
Immuno Metabolic Complexity and Modulating Metabolites
Immunometabolism is a relatively new subspecialty of immunology as we’ve begun to unravel the complex metabolic re ...
OCT 11, 2020
Cancer
Targeting neoantigens to improve immunotherapies
OCT 11, 2020
Targeting neoantigens to improve immunotherapies
Neoantigens are extremely small biomarkers forming from cancer mutations that demonstrate the presence of cancerous cell ...
OCT 18, 2020
Cancer
Virus-mimicking drug attacks melanoma tumors
OCT 18, 2020
Virus-mimicking drug attacks melanoma tumors
Research published recently in the journal Science Translational Medicine from scientists at the UCLA Jonsson Compr ...
Loading Comments...